#MinimalResidualDisease
#Article in #MedComm
The article doi.org/10.1002/mco2... developed an innovative #ctDNA-MRD assay that stands out by combining a personalized panel with a fixed panel for specific cancer types.

#CancerGenomics #MinimalResidualDisease #PersonalizedPanel
Personalized and Tumor Informed Circulating Tumor DNA Assay for Molecular Residual Disease Monitoring of Solid Malignancies
In this study, we developed an innovative ctDNA-MRD assay that stands out by combining a personalized panel with a fixed panel for specific cancer types. This approach enables the monitoring of MRD t...
doi.org
December 19, 2025 at 1:50 AM
🚀 A review in Nature Reviews Clinical Oncology reveals how circulating tumor DNA (ctDNA) is transforming MRD (#MinimalResidualDisease) detection in solid tumors 🧬

@natureportfolio.nature.com

#Onco404 #Cancer #Oncology #LiquidBiopsy #MRD #ctDNA #Healthcare
March 30, 2025 at 6:52 PM